1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

The RNA-dependent RNA polymerase (NS5B) of hepatitis C virus (HCV) is an unusually attractive target for drug discovery since it contains five distinct drugable sites. The success of novel antiviral therapies will require nonnucleoside inhibitors to be active in at least patients infected with HCV o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nyanguile, Origène, Devogelaere, Benoit, Vijgen, Leen, Van den Broeck, Walter, Pauwels, Frederik, Cummings, Maxwell D., De Bondt, Hendrik L., Vos, Ann M., Berke, Jan M., Lenz, Oliver, Vandercruyssen, Geneviève, Vermeiren, Katrien, Mostmans, Wendy, Dehertogh, Pascale, Delouvroy, Frédéric, Vendeville, Sandrine, VanDyck, Koen, Dockx, Koen, Cleiren, Erna, Raboisson, Pierre, Simmen, Kenneth A., Fanning, Gregory C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Vaccines and Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826027/
https://ncbi.nlm.nih.gov/pubmed/20071590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01980-09
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia